Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 19, 2022
Recro Pharma, Inc. announced the appointment of Eduardo Uribe as the company’s head of quality for Recro San Diego. Mr. Uribe has more than 30 years of experience developing, implementing and managing quality systems within the biotechnology and ...
read more
Wednesday, January 19, 2022
PhoreMost Ltd., has relocated its headquarters to Unity Campus, a high-specification technology and innovation park, owned by leading regional property developers and investors, Howard Group, in south Cambridge.
read more
Wednesday, January 19, 2022
Treadwell Therapeutics, a clinical stage, multi-modality biotechnology company developing novel therapeutics for highly aggressive cancers, and Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) have confirmed...
read more
Thursday, January 13, 2022
Procaps Group announced the closing of an asset purchase agreement to acquire an 86,000 sq. ft. pharmaceutical production facility located in Florida with production capacity of approximately 1.8 billion capsules per year.
read more
Thursday, January 13, 2022
Eurofins CDMO announces the expansion of existing Spray Dry Development & Production Services in North America.
read more
Wednesday, January 12, 2022
Performance Cell Manufacturing a contract development and manufacturing organization announced that it has been acquired by Great Point Partners (“GPP”), a Greenwich, Connecticut based private investment firm focused on the healthcare industry.
read more
Wednesday, January 12, 2022
Malvern Panalytical announced its acquisition of Creoptix AG, a specialist bioanalysis sensor company.
read more
Wednesday, January 12, 2022
Sinocompound Catalysts Co., Ltd has partnered with InCatT to launch a specialist Catalyst Screening Service for pharmaceutical, and fine chemical companies looking to optimize their reactions.
read more
Wednesday, January 12, 2022
Catalent has increased cold chain packaging capabilities at its Philadelphia facility to support increased demand for the distribution of biologic drugs, and advanced cell and gene therapies.
read more
Tuesday, January 11, 2022
Avid Bioservices, Inc. announced the official opening of the second downstream processing suite within the company’s existing Myford North facility.
read more
Tuesday, January 11, 2022
Recipharm announced the sale to Astrea Pharma, the newly established CDMO provider focused on small molecule oral solid and aseptic dosages, of the solid dose manufacturing site at Fontaine-lès-Dijon, France.
read more
Tuesday, January 11, 2022
Pharmaron acquires commercial API manufacturing facility in the United Kingdom from Recipharm, and continues to strengthen the global chemistry and manufacturing capabilities and capacities.
read more
Catalent announced that its Board of Directors has appointed Alessandro Maselli, currently President and Chief Operating Officer, as the company’s next President and Chief Executive Officer, effective July 1, 2022.
read more
Research Triangle Park, N.C.-based CATO SMS and Bracknell, U.K.-headquartered Pharm-Olam, both providers of specialized clinical research services, announced today that they are merging to form a leading global biopharmaceutical services organization...
read more
Your input is important as we benchmark current global and regional trends affecting the bioindustry. You will receive, a FREE Aggregated Summary of the results of this important global study, a FREE White Paper - Top Trends in Biopharmaceutical ...
read more